Nalaganje...
Spironolactone Use in Heart Failure Patients With End‐Stage Renal Disease on Hemodialysis: Is It Safe?
BACKGROUND: Spironolactone is used in the treatment of cardiovascular disease, but is contraindicated in renal dysfunction due to the risk of hyperkalemia. It is not known if patients with end‐stage renal disease (ESRD) on hemodialysis are at the same risk for hyperkalemia. The objective of this stu...
Shranjeno v:
| izdano v: | Clin Cardiol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley Periodicals, Inc.
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653125/ https://ncbi.nlm.nih.gov/pubmed/20960534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20838 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|